Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome - PubMed (original) (raw)

doi: 10.1038/nn1860. Epub 2007 Feb 25.

Affiliations

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fabian Fernandez et al. Nat Neurosci. 2007 Apr.

Abstract

Ts65Dn mice, a model for Down syndrome, have excessive inhibition in the dentate gyrus, a condition that could compromise synaptic plasticity and mnemonic processing. We show that chronic systemic treatment of these mice with GABAA antagonists at non-epileptic doses causes a persistent post-drug recovery of cognition and long-term potentiation. These results suggest that over-inhibition contributes to intellectual disabilities associated with Down syndrome and that GABAA antagonists may be useful therapeutic agents for this disorder.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources